Systematix Shares & Stocks (I) Ltd. provides insightful, timely, objective and in-depth research. Our research effort is comprehensive and intensive to enable clients to make informed investment decisions. Our team seeks unique & innovative growth companies where there is a favorable balance between risk & reward, which allows us to provide the best possible recommendations to our clients. The corner stone of our equity research approach remains extensive market research analysis with a view towards the intermediate to long-term goals.

The philosophy and goal of Systematix equity research team is to provide investors with information and investment conclusion on a consistent and unbiased basis and trading strategies with entry and exit points of view. Our research and advisory desk covers the entire gamut of investment options including equities, currencies, derivatives, fixed income, mutual funds and commodities.

Our past research recommendations have consistently outperformed the benchmarks. Systematix research is available not just over the internet but also on international wire services like Bloomberg (Code: SSSL)

Best viewed with 1024x768 resolution in IE 5 and above. Visitors Till Date:
Systematix Shares & Stocks (I) Ltd.
NSE Cash: INB231132730   NSE F&O: INF231132730   NSE CDS: INE231132730
BSE Cash: INB011132736   PMS: INP000002692   Mutual Fund: ARN 64917
CDSL: IN-DP-CDSL-246-2004
Group Company: Systematix Commodities Services Pvt. Ltd.   NCDEX: CO-05-00534   MCX: 29790

Useful links : NSE | BSE | SEBI | NSDL | NCDEX | MCX | CDSL | RBI | FMC | AMFI | Derivatives On NSE| Web Email

Investor Grievance | BSE Investor Complaints | Downloads | Feedback | Sitemap | Disclaimer | Privacy Policy
Copyright 2008-2009 Systematix Group, All rights reserved.
Designed || Developed & Content Powered by Accord Fintech Pvt. Ltd
Please carefully read the risk disclosure document as prescribed by SEBI & FMC and Do’s & Don’ts by NCDEX